Rare blood types hard to find? New ICMR registry could change that
The
ICMR-NIIH
is now in talks with the Director General of Health Services (DGHS) so that the rare donor registry portal can be integrated with e-Raktakosh, a platform which currently provides information about blood availability, Dr Manisha Madkaikar, Director of ICMR-Centre for Research Management and Control of Haemoglobinopathies (CRHCM) in Nagpur said.
The integration will help people with rare blood groups easily trace blood banks and procure blood. It will also assist the blood banks manage their stock and donors through a centralised system.
India, with a population of more than 142 crore, has over 4,000 licensed blood banks, according to the Central Drug Standard Control Organisation (CDSCO).
India relies heavily on transfusions due to a higher prevalence of blood diseases and complications during pregnancy, Dr Madkaikar said.
"Thalassemia itself contributes to 1 to 1.5 lakh patients who require recurrent transfusions," she said.
Additionally, with more than 1,200 road accidents occurring every day in India, and with every year 60 million surgeries, 240 million major operations, 331 million cancer-related procedures, and 10 million pregnancy complications, a serious call for blood transfusion is recognised, she said.
In majority of
blood banks in India
, only ABO and RhD are antigens matched prior to cross-matching for issuing of red blood cell components. However, the International Society of Blood Transfusion (ISBT) has recognised more than 360 antigens in 47 blood group systems. Blood banks do not perform testing of these minor blood group antigens routinely, explained Dr Madkaikar.
"As a result, a mismatch of minor antigens between donor and patient blood group (BG) profiles can lead to red cell alloimmunization (1-3 per cent in the general population, 8-18 per cent in thalassaemic patients). About 25 per cent of all immunized patients have been reported to receive unsatisfactory transfusion support due to presence of multiple antibodies or antibodies to high frequency antigens (HFA)," she said.
Rare blood groups are those which lack HFA (1:1000 or less), or are negative for a combination of common antigens, or have a null phenotype.
"Meeting a demand for rare blood supply is challenging and time consuming for such patients. The need of a patient for rare blood can be the start of a series of events that may extend beyond the local blood centre and become a national or even an international search," Dr Madkaikar said.
To overcome this challenge, an inventory of extensively typed blood donors and rare blood type donors is required, she said.
For this, internationally 27 countries have operational national rare donor registry programmes. India, however, is not a contributor country, she said.
In 2019, however,
ICMR
-NIIH was granted Centre of Excellence project under the aegis of ICMR, where an initiative was taken to screen 4,000 'O' group regular blood donors for all clinically important antigens using high throughput molecular assays, from four different regions of India in collaboration with the big blood banks from KEM Hospital Mumbai, PGIMER Chandigarh, MCH Kolkatta and JIPMER Puducherry.
"More than 600 donors negative for combination of antigens were identified along with 250 very rare blood group donors. The registry also includes 170 Bombay blood group donors, which is the commonly required rare blood type in India (approx 120-150 units/year). To access this inventory (ICMR-Rare Donor Registry of India (RDRI)), a web-based portal has been developed for systematic requisition and provision of blood to patients on time," Dr Madkaikar said.
"There is a plan to integrate this rare donor registry with e-Raktakosh of DGHS so that all the blood banks can contribute their rare donors and help in expansion of the registry. Last month we held a meeting with the DGHS," she said.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
3 hours ago
- Time of India
CDSCO notifies draft standard evaluation protocols for issuing IVD licenses
New Delhi: India's medical device regulator, CDSCO in collaboration with the Indian Council of Medical Research (ICMR) has issued draft standard protocols for evaluating In-Vitro Diagnostics (IVDs) devices quality and performance, to be used for issuing licenses. The protocols are meant to be followed by the country's IVD manufacturers testing labs and the regulator has sought stakeholders' comments over the notified draft by August 25. 'These protocols are now being placed in the public domain for comments from relevant stakeholders. This window of opportunity will close on 25th August 2025, and, once finalized, there will be minimal scope for change in these documents,' the notice reads. The 180-page document details the standard performance evaluation and field evaluation protocol for 15 types of IVDs including Dengue, Malaria, Influenza virus, Nipah virus, Chandipura virus, SARS-CoV-2 molecular detection differentiation assay, among several others. In Vitro Diagnostics (IVDs) are medical devices used to test samples such as blood, urine, or tissue outside the human body, to diagnose diseases, conditions, or infections, and to monitor a person's health based on predefined bio markers. Under the Medical Device Rules of 2017, 'Licensure of In-Vitro Diagnostics (IVDs) requires a detailed evaluation protocol for the performance evaluation of IVDs to evaluate their quality and performance.' The evaluation protocol helps to test the device safety, sensitivity, and accuracy, to validate the device clinical and analytical performance, required for issuing the product license, thereby allowing its usage in the country. In India the ICMR develops evaluation protocols to standardize the process of assessing the performance of diagnostic kits, particularly In Vitro Diagnostics (IVDs) and the CDSCO oversees the evaluation and enforcement of the protocols.
The Print
3 hours ago
- The Print
How to detect early signs of disease outbreak? Govt's plan is to expand wastewater surveillance
The system works as an early detection system for outbreaks, allowing public health officials to better understand and respond to public health threats. People infected with certain viruses and bacteria shed the pathogens in their feces or urine even if they are asymptomatic or do not seek medical care. The initiative led by the Indian Council of Medical Research (ICMR) in collaboration with some other government and private agencies, including the National Centre for Disease Control (NCDC), is set to be rolled out over the next six months. Now identified and deployed as an important public health tool worldwide, it allows authorities to detect disease-causing germs in wastewater by testing for their nucleic makeup in the sewage. New Delhi: The central government has decided to massively expand wastewater surveillance across the country, setting a target for itself to identify more than 10 disease-causing germs. Besides picking early warning signs of outbreaks, the move is also aimed at quicker implementation of strategies to manage infectious diseases. Public health laboratories can then test untreated samples from municipal wastewater facilities and detect the presence and burden of these germs in the population. The pathogens that will be surveilled through the project will include non-typhoidal salmonella, Taenia solium, Entamoeba histolytica, Giardia lamblia, Ascaris, Listeria monocytogenes and Leptospira—that cause serious stomach, liver or diarrheal infections—as well as the highly infectious Mycobacterium tuberculosis and NewCastle disease virus. In addition, said ICMR director general Dr Rajiv Bahl, pathogens causing deadly avian or bird flu will also be surveyed through the project. 'We will test the pathogens that can test … whatever is likely to come in wastewater, we are going to test,' Dr Bahl told ThePrint, adding that most infectious disease outbreaks manifest symptoms like fever, diarrhea and respiratory illnesses. In India, wastewater surveillance was first started in 2001 with the help of the World Health Organization (WHO) to track poliomyelitis or polio-causing viruses as part of the National Public Health Surveillance (NPHS) programme. In 2020, during the COVID-19 pandemic, the programme was expanded to include SARS-CoV-2 strains. The latest expansion of the project, to be conducted through animal-human interface projects in 3 slaughterhouses and 11 bird sanctuaries in different cities, will also include all coronaviruses, ICMR scientists said. The move is particularly significant given the constant threat of massive disease outbreaks of zoonotic origin or viruses that jump from animals and birds to humans, mainly propelled by climate change. Currently, polio virus is routinely tested across the country at 65 sites under the NPHS. Additionally, as an extension of the programme, it is also being deployed to identify antimicrobial resistance (or AMR)—which poses a major threat to public health due to resistance in disease-causing agents against available antibiotics—across 60 hospitals in the country. Also Read: Gut health probiotics now among top selling drugs in India, but doctors advise caution against hype Granular data without individual testing Wastewater surveillance integrates expertise from fields such as public health, ecology, urban planning, and virology, recognising the interconnectedness of human, animal, and environmental health, serving as a key component of the 'One Health' concept. Experts ThePrint spoke to said the standard procedure is wastewater sample collection, nucleic acid extraction and amplification, followed by its testing to quantify pathogens with PCR-based methods (aimed at looking for specific pathogens) or next-generation sequencing (NGS), which is used for variant detection. Given the nature of wastewater which comprises waste from households, livestock and environment and many other components that end up in it, the information generated is significant, and at minimal cost. Dr Rakesh Kumar Mishra, scientist and director of Bengaluru-based Tata Institute of Genetics and Society, who specialises in genomics and epigenetics, told ThePrint that just a few samples, from cities with millions of people, for example, can indicate the circulating pathogens without testing individuals. For instance, in cities with good sewage systems, it is possible to detect pathogens specific to a locality. The surveillance is more effective in generating crucial and granular pathogen-related information from cities with better planned sewage systems but can also give a rough idea from others, said Dr Mishra. Dr Mishra is also the chief principal investigator of the Alliance for Pathogen Surveillance Innovations (APSI), which is a multi-city consortium of research, clinical, public and private institutions. APSI has been working with the ICMR and NCDC on the wastewater surveillance project. Scientific studies have established that detecting viruses in wastewater gives decision-makers a lead time of 10-14 days. This time can be vital for public health authorities to re-look at priorities, reallocate human resources, vaccinate targeted groups and alert the medical fraternity. This is what happened in Canada in 2023 during an outbreak of Respiratory Syncytial Virus or RSV—a pathogen that can lead to high numbers of hospitalisation. (Edited by Amrtansh Arora) Also Read: ICMR confirms diarrhoeal pathogen in Guillain-Barre Syndrome case samples but cause of outbreak unclear
Indian Express
5 hours ago
- Indian Express
Wastewater surveillance, key tool to spy on diseases, will now cover 50 cities: How will this help prevent outbreaks?
A key public health tool that is crucial to monitor infectious diseases, and identify outbreak trends early, is being strengthened to cover more areas and identify more infections. Wastewater surveillance, which is currently used for polio and Covid-19, is now being deployed to monitor more commonly reported symptoms caused by several pathogens, such as fever, diarrhoea, acute encephalitis syndrome (inflammation of the brain), and respiratory distress. 'We have been doing wastewater surveillance for polio for years. After the pandemic, similar surveillance for Covid-19 was also started in five cities. This will be expanded to ten pathogens across 50 cities over the next six months,' Dr Rajiv Bahl, Director-General of Indian Council of Medical Research (ICMR), told The Indian Express. Why is this coverage arc significant? Such an expansion has significant public health implications since it is being done with the aim of detecting potential outbreaks early, as well as identifying unusual patterns that may indicate a public health concern. The surveillance will also study patterns of antimicrobial resistance — a global public health threat — that results in the drugs becoming less effective, making it difficult to treat infections. At present, tracking changes in the susceptibility of different pathogens to available antimicrobials is being done through a network of 60 hospitals across the country. 'Now, rather than conducting culture studies only on patients coming to these hospitals, these will also be studied in wastewater,' said Dr Bahl. While antimicrobial resistance surveillance through a hospital network can provide important trends on which drug continues to work for which disease, it cannot track resistance patterns in the community. Wastewater surveillance, on the other hand, can capture these patterns — even in those who might not go to a hospital for treatment. How will the surveillance be carried out? The enhanced surveillance will be carried out through the ICMR's (Indian Council of Medical Research) flagship national network of Viral Research and Diagnostic Laboratories: specialised facilities that focus on the diagnosis, research and surveillance of viral diseases. In the next few months, these laboratories will supplement the findings from patient samples with surveillance of pathogens discharged in wastewater. What's the current surveillance status in India? There is already strong syndromic surveillance for respiratory infections and influenza-like illnesses — instituted after the 2009 swine flu pandemic and strengthened during Covid-19. Around 1,500 samples from patients, who go to hospitals with respiratory symptoms, are tested every week through this national network of laboratories, according to Dr Bahl. Earlier, the network passively monitored whatever samples were sent by the hospitals but now the labs actively seek out the samples needed to maintain surveillance. This helps keep an eye on which respiratory diseases — viral infections such as Covid-19, H1N1, or RSV — are in circulation. It also helps pre-empt outbreaks, allowing the public health system, hospitals, and clinics to prepare for them. Similar syndromic surveillance for fevers, diarrhoea and encephalitis has been initiated recently through the laboratory network. Now, the surveillance will be expanded to wastewater in the coming months. Such surveillance also helps in quickly identifying the pathogen that might be causing an infection by checking the samples for common pathogens that can cause a disease — instead of testing for them one by one. 'And, if we cannot detect the pathogen, then genomic sequencing can be done to find what is causing an outbreak,' said Dr Bahl. Wastewater surveillance proved to be an effective tool in tracking Covid-19. A study from Mumbai shows that the pathogen was detected in wastewater up to three weeks before clinical diagnosis of cases. Another study from Pune showed that silent waves of Covid-19 after the Omicron wave could be detected in wastewater. The XBB variant was detected 130–253 days before it was clinically identified in patients.
